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Abstract
Background: We developed an extendable open-source Loop-mediated isothermal AMPlification (LAMP) signature
design program called LAVA (LAMP Assay Versatile Analysis). LAVA was created in response to limitations of
existing LAMP signature programs.
Results: LAVA identifies combinations of six primer regions for basic LAMP signatures, or combinations of eight
primer regions for LAMP signatures with loop primers, which can be used as LAMP signatures. The identified
primers are conserved among target organism sequences. Primer combinations are optimized based on lengths,
melting temperatures, and spacing among primer sites. We compare LAMP signature candidates for Staphylococcus
aureus created both by LAVA and by PrimerExplorer. We also include signatures from a sample run targeting all
strains of Mycobacterium tuberculosis.
Conclusions: We have designed and demonstrated new software for identifying signature candidates appropriate
for LAMP assays. The software is available for download at http://lava-dna.googlecode.com/.
Background
Loop-mediated isothermal amplification (LAMP) is a
DNA amplification technique with high specificity, effi-
ciency, and speed, performed under isothermal condi-
tions [1]. We are using LAMP to perform highly
sensitive and specific detection of blood-borne patho-
gens with a new point-of-care instrument that is in
development, targeting pathogens such as Staphylococ-
cus aureus, Pseudomonas aeruginosa, and Streptococcus
pneumoniae. This approach has the potential to operate
at significantly lower cost than TaqMan PCR detection
because it can be performed with less expensive materi-
als and equipment [2,3].
The most common method for designing LAMP pri-
mers is to use PrimerExplorer V4 from Eiken Chemical
Co. Ltd. http://primerexplorer.jp/e/index.html. While
PrimerExplorer is very useful for LAMP signature
design, as demonstrated by its widespread use, it has
several limitations that reduced its usability for our
high-throughput whole-genome analysis. First,
PrimerExplorer doesn’t support IUPAC characters other
than “ATCG” in the input sequence, which are often
used in MSA representations, because it was not built
to handle MSA representations. Second, PrimerExplorer
only runs in Windows operating systems, in a specific
web browser. Third, PrimerExplorer cannot design sig-
natures with loop primers, as discussed in Nagamine et
al. [4] in a single execution, instead requiring two serial
executions, which can prevent more optimal primer
combinations from being identified. And fourth, Primer-
Explorer is less suited for high throughput analysis since
it is limited to a single execution process on a computer,
accepts only up to 2,000 bp sequences, and outputs only
HTML.
LAVA is designed to be a flexible tool for custom sig-
nature design, so it can fulfill varying signature design
needs in a high-throughput informatics environment.
LAVA was implemented in Perl because Perl inter-
preters are available for every major operating system,
the wide use of BioPerl [5] in bioinformatics, and Bio-
Perl’s support for several different sequence alignment
formats. To simplify discussion of signature design, we
refer to LAMP primers as pairs of nested primers: inner,* Correspondence: clinton.torres@llnl.gov
Lawrence Livermore National Laboratory, Livermore, California, USA
Torres et al. BMC Bioinformatics 2011, 12:240
http://www.biomedcentral.com/1471-2105/12/240
© 2011 Torres et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
loop, middle, and outer, as shown in Figure 1. All signa-
ture results from LAVA are read in the 5’ to 3’ direc-
tion, even if the opposite strand is used to design a
portion of the sequence, and are consistent with the tra-
ditional nomenclature in Notomi et al. [1].
Implementation
This is a Multiple-Sequence Alignment (MSA) approach
to LAMP signature design. LAVA’s processing steps are
outlined in Figure 2. Either a single sequence or a pre-
computed MSA can be used as input. The individual
sequences from the MSA are used for primer enumera-
tion, and design parameters can be adjusted for each
primer role. Once potential primer locations are found,
they are usually down-selected based on overlap and
relative score, which keeps the number of analyzed com-
binations down. After primers have been identified that
are shared among all the individual sequences, combina-
tions of primers for the roles of inner, loop, middle, and
outer, are analyzed to select LAMP signature candidates.
Find Potential LAMP Primers
MSAs are read as input with BioPerl’s Bio::AlignIO
module, which understands many different alignment
formats. Long MSAs can sometimes be used as input,
but have heavy computer resource requirements, and
using long MSAs can result in fewer identified signature
candidates.
LAMP signatures that cover individual non-MSA
sequences 20 kbp in length can take up to 90 minutes
on a desktop computer if few design constraints are spe-
cified. Identification of signatures for MSAs of this type
is usually finished in minutes, because only regions of
conservation are considered in this version of LAVA.
MSAs can have both longer and shorter runtimes,
depending on the content of the MSA. MSAs approach-
ing 100% conservation will run similar to single
sequences. As the level of conservation decreases, so
will LAVA’s runtime up to a point.
We suggest using the LAVA wrapper SLAVA (Serial-
LAVA) for individual sequences and highly conserved
MSAs over 10 kbp. SLAVA splits the MSA into sec-
tions, executes LAVA for each individual section, and
combines the results into a single set of non-identical
signatures. Running a series of smaller chunks through
SLAVA is likely to result in more optimal signature
combinations, because each sub-analysis can identify
more primer candidate regions.
Primer enumeration is performed by modules which
implement the OligoEnumerator interface. By default,
this is done with Primer3 [6], executed through BioPerl’s
Bio::Tools::Run::Primer3 module. The primer search is
separately run for each primer context of inner, loop,
middle, and outer. Default primer design parameters,
which can be individually customized, were chosen
based on our primer design rules for other primer-based
amplification techniques [7]. LAVA’s default primer
design parameters are listed in Table 1, along with other
relevant parameter defaults discussed in this section.
These defaults should only be considered as a starting
point for signature identification, because a wide range
of parameters yield successful LAMP assays.
The first sequence in the MSA is the basis for gener-
ating primers. The remaining MSA sequences are used
to filter out primers that are not identically present in
every target sequence. Sub-sequence with “N” or “-”
characters is not considered a valid primer target. Pri-
mers that are shared among all MSA sequences are
returned as potential signature components by the Oli-
goEnumerator. During primer generation, a maximum
poly-base restriction is enforced, limiting number of
consecutive identical bases in a potential primer region.
Primer analysis and scoring is performed by PrimerA-
nalyzer modules. Penalties get applied to primers and
combinations of primers in two separate places. First is
as an individual primer, and second is as a combination
of primers for a LAMP signature. The PrimerAnalyzer
penalty for individual primers in this version of LAVA
is simply the Primer3 penalty score, which reflects how
closely the primer comes to the design parameters. For
combinations of primers, the penalty also includes fac-
tors for for inter-primer spacing. The assessment of the
primer by the PrimerAnalyzer is returned as PrimerInfo
objects, which are used to provide primer sequence
information for signature output. This may appear
redundant because the primers already contain the
Figure 1 Additional description of a LAMP signature. Each named pair refers to a sequence location corresponding to the primer regions of
like-numbered primers. These pairs represent the location and orientation of the primers with respect to the target template during each
extension in which they participate.
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original sequence information, but since different scores
can exist for the same primer in different roles, and
some analysis methods may impose context-sensitive
sequence restrictions as part of score calculation, relying
on PrimerInfo guarantees that the correct sequence is
associated with the analysis result for each context.
Filter Down By Overlap And Score
To help control the number of primer combinations
that need to be scored, the set of candidate primer
regions is down-selected based on overlap. Many poten-
tial primers often target the same general sequence
region. Of the available primers, the best scoring pri-
mers are given priority during down-selection. The
lower scoring overlapping primers are removed from
consideration if they overlap the higher priority primers
by a given percentage.
Evaluate Primer Combinations
Finally, primers are combined into nested sets that can
serve as LAMP signatures. The overall LAMP signature
penalty is the weighted combination of inner, middle, and
outer pair penalties, plus context-dependent spacing penal-
ties. Inter-primer spacing penalty increases as distance
increases. The default objective function includes slightly
decreasing weights for the penalties of inner primers, mid-
dle primers, outer primers, and loop primers respectively.
If the minimum number of signatures is not identified
for the target, the entire primer combination process is
repeated with different primer overlap cutoff percentages.
The amount of overlap permitted is set for each iteration,
based on a “schedule” of primer overlap percentages.
Since these repeat attempts are effectively multiple runs
of LAVA, often with more individually considered pri-
mers, regions with difficult to identify signatures will take
longer to process. Processing time can increase exponen-
tially as the primer overlap restrictions become lighter.
Results
We created LAMP signatures with both LAVA and Pri-
merExplorer for comparison. The locus we targeted is
an 800 base-pair long sequence of Staphylococcus aur-
eus, starting at base 2464089 of the RF122 genome
[GenBank: NC_007622.1] at the 3’ end of gltA through
the 5’ start of gltB. This locus is interesting to us
because it is a place where a KPATH [7] run identified
a TaqMan signature candidate that is both conserved
among all targets, and is unique to the targets compared
to all other known sequence, which makes this candi-
date region potentially valuable for S. aureus detection.
Input for signature design was a sequence representa-
tion of all the genome sequences in Table 2.
Table 1 Default values of the most commonly adjusted
LAVA parameters
Parameter Default Target
Outer primer length 18-23 bp
Middle primer length 18-23 bp
Loop primer length 18-23 bp
Inner primer length 20-26 bp
Outer primer Tm 59-61°C
Middle primer Tm 59-61°C
Loop primer Tm 58-62°C
Inner primer Tm 62-66°C
Maximum signature length 320 bp
Minimum spacing from middle to inner primers 25 bp
Maximum consecutive repeated bases 5
Figure 2 Schematic diagram of LAVA. MSAs are used as input. Potential primers are found based on the MSA content, and paired in all
reasonable configurations as inner primers. The remaining primers are then selected based on the scoring of potential combinations.
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Eiken’s PrimerExplorer was run with default para-
meters. LAVA was run with parameters designed to be
similar to the PrimerExplorer defaults, but with an
adjusted melting temperature target range to compen-
sate for the difference in calculated temperatures
between Primer3 and PrimerExplorer. These parameters
specifically allow a wider acceptable TM range from
LAVA’s defaults, and a longer poly-base limit. The best
scoring signature results from both programs are pro-
vided in Table 3.
The LAVA selection for a lamp signature is nearly
identical to the PrimerExplorer selection, as seen in Fig-
ure 3. We believe the variations between result sets are
the result of subtle differences in calculation methods
for primer metrics, and would not represent a signifi-
cant difference in signature behavior. It is likely that
LAVA penalizes Tm differences slightly more than Pri-
merExplorer. The result is that LAVA’s top signature
selection has a slightly smaller range of melting
temperatures.
As an additional example case, we’ve also created
LAMP signature candidates for Mycobacterium tubercu-
losis, as listed in Table 4, using default LAVA para-
meters. We have not screened these in the laboratory,
but they represent conserved and unique signatures that
we believe would make sensitive and specific detection
assays, similar to some of the assays in Iwamoto et al.
[9]. A pre-computed MSA of all 25 completed Mycobac-
terium tuberculosis genomes available was used as
input, including known drug-resistant genomes, and
non-unique regions were masked out so only unique
sequence is used for signature design.
Table 2 Strain sequences used for LAMP signature comparison between LAVA and PrimerExplorer
GenBank GI Number GenBank Accession Number Sequence Description
82749777 NC_007622.1 Staphylococcus aureus RF122, complete genome
148266447 NC_009487.1 Staphylococcus aureus subsp. aureus JH9, complete genome
150392480 NC_009632.1 Staphylococcus aureus subsp. aureus JH1, complete genome
57634611 NC_002758.2 Staphylococcus aureus subsp. aureus Mu50, complete genome
29165615 NC_002745.2 Staphylococcus aureus subsp. aureus N315, complete genome
21281729 NC_003923.1 Staphylococcus aureus subsp. aureus MW2, complete genome
88193823 NC_007795.1 Staphylococcus aureus subsp. aureus NCTC 8325, complete genome
57650036 NC_002951.2 Staphylococcus aureus subsp. aureus COL, complete genome
49482253 NC_002952.2 Staphylococcus aureus subsp. aureus MRSA252, complete genome
49484912 NC_002953.3 Staphylococcus aureus subsp. aureus MSSA476, complete genome
87159884 NC_007793.1 Staphylococcus aureus subsp. aureus USA300, complete genome
161508266 NC_010079.1 Staphylococcus aureus subsp. aureus USA300_TCH1516, complete genome
151220212 NC_009641.1 Staphylococcus aureus subsp. aureus str. Newman, complete genome
156978331 NC_009782.1 Staphylococcus aureus subsp. aureus Mu3, complete genome
Table 3 LAMP signature candidate regions for S. aureus, as generated by both LAVA and PrimerExplorer. Tm
calculated with BioPerl using calculations from SantaLucia(8) with 50 mg/L salt concentration and 50 ng/L oligo
concentration
Program Primer Sequence Tm (C) 5’ Location Length
LAVA F1 GGAATAGTTTGTAAGACACCTGCCA 55.82 149 25
F2 ACCAACACCAAAAATCGGT 50.22 103 19
F3 GCTACAATTGCAGGCGTTT 51.66 83 19
B1 CAAAAACAAAGCGAACTGCCAAT 54.18 209 23
B2 TGGCATTATTACTTGCCATCA 50.38 260 21
B3 TTGATGTCGAAAACACTGGAA 50.63 300 21
PrimerExplorer F1 TGTTGGAATAGTTTGTAAGACACCT 53.22 145 25
F2 TTACCAACACCAAAAATCGG 48.91 101 21
F3 GCTACAATTGCAGGCGTT 50.80 83 18
B1 CAAAAACAAAGCGAACTGCCAATA 53.99 209 24
B2 GCATTATTACTTGCCATCATTG 48.63 258 22
B3 TGTCGAAAACACTGGAACAT 50.11 296 20
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Discussion
When developing LAVA, getting usable LAMP signa-
tures was our priority, so we have not spent time on
optimizations, or on many of the features we desire.
Operationally, LAVA has fulfilled our needs, but there
are several components that are worthy of further atten-
tion. This discussion explores aspects of LAVA’s design
and operation that we believe will improve or augment
LAVA’s performance the most.
LAVA currently excludes dimerization checks during
primer selection, which would contribute to the relative
scores of signature candidates. This would have been
accomplished using the UNAFold [10] libraries to ana-
lyze inter-oligo interactions, and primer self-annealing.
This is currently omitted because in some instances, the
increase in required processing time to analyze primer
combinations was unacceptable. Predicting inter-oligo
hybridization is still a serious concern with regards to
LAMP signature design, so we separately perform
dimerization analysis on the finished signature candi-
dates, and avoid using candidates with high dimerization
potential. We will include dimerization checks as part of
the native signature design when possible.
There are two primary options for controlling the
number of primer combinations that need to be ana-
lyzed. The first is limiting the number of primer candi-
dates that Primer3 can identify in each execution. This
can be accomplished by narrowing the acceptable range
of primer design parameters such as length and melting
temperature. Primer3 output can also be limited by
explicitly setting a maximum number of primers for Pri-
mer3 to generate. The second option is to set stricter
primer overlap limits. Stringent overlap limits may make
it possible to perform the comprehensive dimerization
checks discussed above within reasonable processing
times.
We have observed through computer predictions
including [10], that an optional linker sequence, used to
connect the two components of the FIP and BIP (F1c
and F2, and B1c and B2 respectively), has the potential
to disrupt the LAMP reaction. In general, calculations
based on a “TTTT” linker sequence predict a slight
increase in sensitivity in many of the likely hybridization
configurations, because of a slightly longer and more
stable base pairing at the 5’ end of the hybridization.
However, in one instance, this linker greatly increased
predicted primer self-hybridization because of an unfor-
tunate co-incidence of self-similar sequence. The chance
of this being a problem increases if the number of con-
secutive identical bases in the designed primers cannot
be limited. Improper choice of linker sequence can also
increase predicted primer dimerization. A more context-
aware linker design should yield better results than
always using a single linker sequence. One day, we hope
LAVA will suggest the most appropriate linker
sequence, or omission of the linker, for each designed
signature, to help support desired assay behavior. One
potential approach is to design linkers that are the least
Figure 3 Signature layout of PrimerExplorer and LAVA results. This shows results for the specified S. aureus sequence locus, where ‘N’
characters represent bases not perfectly conserved across all targets. PrimerExplorer results are highlighted, and LAVA results are repeated above
or below the double-stranded sequence as appropriate.
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complimentary to the loop regions adjacent to the F1
region in the LAMP dumbbell structures as possible.
Another potential approach is to design linker-free pri-
mers like Poon et al [11], which is currently the default
behavior of LAVA.
When designing LAMP signatures, we found there is a
general pattern we fell into of relaxing design para-
meters to identify signatures for difficult to target
sequences. On average, the order which we adjusted
parameters were to increase melting temperature range,
decrease primer minimum length, and finally to increase
signature max length.
The LAVA wrapper SLAVA was implemented as a
serial execution of individual MSA segments. This is
provided to enable signature design for long sequences
such as whole bacterial genomes, and also to demon-
strate how a parallel implementation would be struc-
tured. During the further development of LAVA, we
hope to transition into a high-performance grid comput-
ing environment with a parallel LAVA implementation.
We are separately developing a OligoEnumerator for
creating primers with degeneracy, which are primers
with base variations designed to accommodate strain
variation. So far, we have used a “masked” MSA repre-
sentation of the target to design signatures. However,
since Primer3 does not accept sequence containing the
standardized IUPAC character codes, the MSA repre-
sentation has so far been limited to perfect consensus
Table 4 LAMP signature candidates for Mycobacterium tuberculosis, with gene targets based on the reference H37Rv
genome [GenBank: NC_000962.2]. The hyphen in FIP and BIP sequences represents where the two segments should
be linked together
Signature Size Gene Part Sequence Length
mTub228 275 bp Rv0987 F3 CGCTCTCAGTTTGATTGCCT 20 bp
B3 CATTGCGAACATTGATGACA 20 bp
FLoop CTCGGGTTACACCCAAACAG 20 bp
BLoop CTTGATTGGAATTTGGCTCG 20 bp
FIP GGATTCCGTCATTATCAGCCAAA-GACCGTTTTTCGCCATATTG 43 bp
BIP CTGATTGGTACGGGCTTGGG-TGATGGTTTGAGTCACCAGG 40 bp
mTub229 195 bp Rv0988 F3 AATGGCACCGCTTTGATG 18 bp
B3 AATTTCGATTTCCCATGCAA 20 bp
FLoop CTGGAAAATCGGGTCACACT 20 bp
BLoop ATTTCCGCATCAAGACGACT 20 bp
FIP CATCCCCGGCAACAAAGGTA-TTTTCAGATTCGACAGGCG 39 bp
BIP GTGATCCCTCTCGAGTCGTCC-CACTCTGGTCACTGGTCCAA 41 bp
mTub230 252 bp Rv1290c F3 GACACCACGATCAGCACG 18 bp
B3 CGTAGTTCCGCCTAGTGCTC 20 bp
FLoop GTCGATGATTCCCGTGAAAT 20 bp
BLoop ACGGTTGAGCATGCTGGT 18 bp
FIP AGTCTGGGTGCTGCCGACAT-GCCCTGAAACATCAGCTTGT 40 bp
BIP CGCCCTGTAAGTAATCCAGTATGG-GGATGGGTGCATGCTTATTC 44 bp
mTub231 235 bp tyrS
(approx)
F3 GATTGGGAGGTGATGAGACC 20 bp
B3 CTAGTCGTGGGATACCAGCG 20 bp
FLoop CGTACTCGATCCCGTTGTTC 20 bp
BLoop TGCGTTGTAGTCGATTTCCA 20 bp
FIP TCACACGCACAGCTGTTTAGTGA-TAGTGCGTTGACCTCACTCG 43 bp
BIP CATCATCCTTTCATGTGACAGGC-CCGCCAAAGATAAGTCAGGA 43 bp
mTub232 230 bp Rv2735c and recX F3 CGGTCTATGTTCTCGGGCT 19 bp
B3 GTGGGTACGGCCAGACCT 18 bp
FLoop GCCTTCAACAGGGCTAGTCA 20 bp
BLoop CATCGAATCCCTTTAGACGC 20 bp
FIP AACAAACTGGAGATACTTGCCGG-GTCGAGGTAAATTCGTTCACG 44 bp
BIP CGCGTCCAATATGACCATTCTCTA-GTGGTTATCGCCGAGCTG 42 bp
Torres et al. BMC Bioinformatics 2011, 12:240
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sequence. The fundamental difference in approach for
designing primers with degeneracy, is that primers are
enumerated based on all the sequences of the MSA,
instead of based on only the first sequence. Our proof
of concept requires different internal representations of
sub-sequence MSAs, but is built using the existing Oli-
goEnumerator and PrimerAnalyzer interfaces.
Conclusions
We have designed and demonstrated new software for
identifying signature candidates appropriate for LAMP
assays. LAVA is available as open source, downloadable
from the project home page. The focus of LAVA is to
improve on other currently available software by accom-
modating high-throughput signature design, while pro-
viding a framework to develop more sophisticated
algorithmic and analytical tools. We have used LAVA to
design LAMP signatures for several organisms, which
are currently undergoing bench screening and optimiza-
tion for use in a point-of-care detection instrument.
Availability and Requirements
Project name: LAVA-DNA




BioPerl 1.5.2 or higher [http://www.bioperl.org/]
Primer3 1.0 or higher [http://primer3.sourceforge.net/]
License: BSD
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